| Name | Title | Contact Details |
|---|
Savista is a prominent provider of healthcare revenue cycle management services. Savista partners with healthcare organizations to problem solve and deliver revenue cycle improvement services that enable their success, support their patients, and nurture their communities. We integrate knowledge and expertise of the revenue cycle to provide financial and operational performance benefits for healthcare organizations of any size. Our global organization of 4,000 colleagues partners with more than 330 US-based healthcare clients, delivering custom solutions to help solve their business challenges.
BeWellNM has established its online communities to serve as informative and engaging resources for the public. Our goal is to facilitate a constructive, open dialogue around the Patient Protection and Affordable Care Act, and to answer questions relate...
Ritter Pharmaceuticals, Inc. is a specialty pharmaceutical company developing therapeutics based upon colonic adaptation to treat gastrointestinal diseases with an initial focus on lactose intolerance. Colonic adaptation improves colon function by selectively increasing the growth of beneficial bacteria in the colonic ecosystem (digestive tract). Ritter Pharmaceuticals, Inc. is rapidly establishing itself as the world`s leader in lactose intolerance research based upon its scientific team and their cutting edge research in this field. RP-G28, Ritter`s lead product, has been studied in a Phase 2 trial and is a first-in-class compound. RP-G28 has the potential to become the first FDA-approved drug for the treatment of lactose intolerance, a debilitating disease which affects over 1 billion people worldwide.
Decade of Discovery is a major research initiative led by the Minnesota Partnership for Biotechnology and Medical Genomics focused on preventing, optimally treating and ultimately curing diabetes.
The Endocrinology Group is a Arlington, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.